Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF AUGUST 14, 2015 FBO #5012
SOLICITATION NOTICE

76 -- Brand Name or Equal MedTrack Database Licenses for Five (5) Users

Notice Date

8/12/2015
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

541519 — Other Computer Related Services
 

Contracting Office

Department of Health and Human Services, Program Support Center, Division of Acquisition Management, 12501 Ardennes Avenue, Suite 400, Rockville, Maryland, 20857, United States
 

ZIP Code

20857
 

Solicitation Number

N02CO52661-85
 

Archive Date

9/8/2015
 

Point of Contact

Megan Kisamore, Phone: 2402765261
 

E-Mail Address

megan.kisamore@nih.gov
(megan.kisamore@nih.gov)
 

Small Business Set-Aside

Total Small Business
 

Description

This is a combined synopsis/solicitation for commercial items, prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation: No. N02CO52661-85 includes all applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2005-81, simplified procedures for commercial items. This acquisition will be conducted under the procedures for acquiring commercial items authorized in FAR Part 12 and under the authority to use simplified procedures for commercial requirements as provided in FAR 13.501. This requirement is assigned North American Industry Classification System (NAICS) code 541519 with a size standard of $25 Million is being considered. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. THIS IS A TOTAL SMALL BUSINESS SET - ASIDE. BACKGROUND The U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI), Office of the Director (OD), Technology Transfer Center (TTC), plans to procure Brand Name or Equal MedTrack Database Licenses for five (5) users. The mission of the TTC Marketing Group is to locate potential collaboration partners that would be interested in developing research discoveries from the NIH Intramural Research Program; to conduct due diligence on potential partners; and to understand the landscape of a wide variety of drug development efforts. TTC therefore requires access to timely data that describe the relative importance of different inventions and patents, and whether the cost of patenting them will be worth the time, effort, and costs. An integrated application is needed to aggregate the wide variety of database information sources. The salient characteristics that apply to this acquisition are as follows: • Comprehensive, integrated platform provides the development pipelines of small, medium, and large domestic and international pharmaceutical and biotechnology companies; • Provides information to relevant business development, competitive intelligence, marketing, market research, and valuations; • Provides unlimited, on-demand research support; • Provides unlimited technical support within 24 hours; • Provides unlimited, on-demand training; • Provides unlimited, customizable watch lists and email alerts to monitor development activities across all of the aggregated platforms; • Integrated platform provides unique capability to search across different databases simultaneously: o Past, present and forecasted sales of products-- can provide valuation estimates of NIH discoveries; o Proprietary royalty database indicates royalties paid on licensed products-- can enable TTC to estimate the valuation of NIH discoveries; o Companies' spending on research and development; o Companies' intellectual property such as patents; o Deals such as collaborations, mergers, and acquisitions; o Start-up companies' venture financing, grants, and contracts; o Therapeutics' modes of action, mechanisms of action, composition and structure, brand and generic names, biological targets, clinical trial information, and development history; o For due diligence, can investigate potential licensee history, including finances, investments, existing partnerships, management and their experience, IP portfolio, and drug pipeline (developmental, marketed, withdrawn drugs). • Estimate valuations of NIH developmental drugs based on companies' financing rounds, public offerings, and disclosed financials • Scheduled clinical trial and regulatory milestones, patent expiries, and sales forecasts for estimating a product's sales and royalties; • Epidemiology studies that describe diseases, size and distribution of markets, and current and developing therapies for those diseases; • Contains contact information and biographies of company managers and executives; • The data is updated real-time; • The user interface is easy to learn, with a Basic Search feature that is important for quick searches or for new users; • A multi-tier, menu-driven Advanced Search integrates many different functions and search fields from multiple databases; • Broad coverage of the patents behind current and in-development pharmaceutical and biotechnology products, and this is helpful in finding partners; • Visualization of large, complex datasets to identify trends and relationships, and create dynamic timelines of drug development PAYMENT Payment shall be made upon the delivery and acceptance of all required items listed in the SOW. CONTRACT CLAUSES/PROVISIONS The following Federal Acquisition Regulation and Health & Human Services Acquisition Regulation Provisions/Clauses apply to this acquisition: FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es): http://www.acquisition.gov/far/ and/or http://www.hhs.gov/policies/hhsar/. FAR 52.212-1 INSTRUCTIONS TO OFFERORS-COMMERCIAL ITEMS (APR 2014) FAR 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS- COMMERCIAL ITEMS (MAR 2015) FAR 52.212-4 CONTRACT TERMS AND CONDITIONS-COMMERCIAL ITEMS (MAY 2015) HHSAR 352.222-70 CONTRACTOR COOPERATION IN EQUAL EMPLOYMENT OPPORTUNITY (JAN 2010) HHSAR 352.242-71 TOBACCO-FREE FACILITIES (JAN 2006) FAR 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS- COMMERCIAL ITEMS (MAY 2015). The following FAR clauses cited in paragraph (b) of the clause at FAR 52.212-5 are also applicable to this acquisition: FAR Clause 52.203-6 Restrictions on Subcontractor Sales to the Government FAR Clause 52.203-13 Contractor Code of Business Ethics and Conduct FAR Clause 52.204-10 Reporting Executive Compensation and First Tier Subcontract Awards FAR Clause 52.209-6 Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment FAR Clause 52.209-9 Updates of Publicly Available Information Regarding Responsibility FAR Clause 52.219-6 Notice of Total Small Business Set-Aside FAR Clause 52.219-8 Utilization of Small Business Concerns FAR Clause 52.219-28 Post Award Small Business Program Representation FAR Clause 52.222-3 Convict Labor FAR Clause 52.222-19 Child Labor-Cooperation with Authorities and Remedies FAR Clause 52.222-21 Prohibition of Segregated Facilities FAR Clause 52.222-26 Equal Opportunity FAR Clause 52.222-35 Equal Opportunity for Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans FAR Clause 52.222-36 Affirmative Action for Workers with Disabilities FAR Clause 52.222-37 Employment Reports of Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans FAR Clause 52.222-40 Notification of Employee Rights Concerning Payment of Union Dues or Fees FAR Clause 52.223-18 Encouraging Contractor Policies to Ban Text Messaging while Driving FAR Clause 52.225-5 Trade Agreements FAR Clause 52.225-13 Restrictions on Certain Foreign Purchases Far Clause 52.232-33 Payment by Electronic Funds Transfer-System for Award Management FAR Clause 52.247-64 Preference for Privately Owned U.S.-Flag Commercial Vessels FAR 52.211-6 BRAND NAME OR EQUAL (AUG 1999) (a) If an item in this solicitation is identified as "brand name or equal," the purchase description reflects the characteristics and level of quality that will satisfy the Government's needs. The salient physical, functional, or performance characteristics that "equal" products must meet are specified in the solicitation. (b) To be considered for award, offers of "equal" products, including "equal" products of the brand name manufacturer, must-(1) Meet the salient physical, functional, or performance characteristic specified in this solicitation; (2) Clearly identify the item by- (i) Brand name, if any; and (ii) Make or model number; (3) Include descriptive literature such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer; and (4) Clearly describe any modification the offeror plans to make in a product to make it conform to the solicitation requirements. Mark any descriptive material to clearly show the modification. (c) The Contracting Officer will evaluate "equal" products on the basis of information furnished by the offeror or identified in the offer and reasonably available to the Contracting Officer. The Contracting Officer is not responsible for locating or obtaining any information not identified in the offer. (d) Unless the offeror clearly indicates in its offer that the product being offered is an "equal" product, the offeror shall provide the brand name product referenced in the solicitation. HHSAR 352.203-70 ANTI-LOBBYING (MAR 2012) Pursuant to the current HHS annual appropriations act, Public Law 112-74, except for normal and recognized executive-legislative relationships, the Contractor shall not use any HHS contract funds for: (a)Publicity or propaganda purposes; (b)The preparation, distribution, or use of any kit, pamphlet, booklet, publication, electronic communication, radio, television or video presentation designed to support or defeat the enactment of legislation before the Congress or any State or local legislature or legislative body, except in presentation to the Congress or any State or local legislature itself; or designed to support of defeat any proposed or pending regulation, administrative action, or order issued by the executive branch of any State or local government, except in presentation to the executive branch of any State or local government itself; or (c)Payment of salary or expenses of the Contractor, or any agent acting for the Contractor, related to any activity designed to influence the enactment of legislation, appropriations regulation, administrative action, or Executive order proposed or pending before the Congress or any State government, State legislature or local legislature or legislative body, other than for normal and recognized executive-legislative relationships or participation by an agency or officer of a State, local or tribal government is policymaking and administrative processes within the executive branch of that government. The prohibitions in subsections (a), (b), and (c) above shall include any activity to advocate or promote any proposed, pending, or future Federal, State or local tax increase, or any proposed, pending, or future requirement for, or restriction on, any legal consumer product, including its sale or marketing, including, but not limited to, the advocacy or promotion of gun control. SUBMISSION INFORMATION Proposals must be submitted on an SF-1449 with a completed 52.212-3 Offeror Representations and Certifications-Commercial Items-with DUNS Number Addendum, signed by an authorized representative of the offeror OR provide a copy of valid certification in the System for Award Management (SAM) at www.sam.gov. Questions must be submitted electronically (via email) to Contract Specialist, Megan Kisamore, at megan.kisamore@nih.gov in MS Word or Adobe Portable Document Format (PDF), no later than Monday, August 17, 2015, 11:00 am, EST. Proposals must be submitted electronically (via email) to Contract Specialist, Megan Kisamore, at megan.kisamore@nih.gov in MS Word or Adobe Portable Document Format (PDF), no later than Monday, August 24, 2015, 11:00 am, EST. All responses must be received by the specified due date and time in order to be considered. PROPOSALS RECEIVED AFTER THIS DATE AND TIME WILL NOT BE CONSIDERED. No collect calls will be accepted. Please refer to solicitation no: N02CO52661-85 on all correspondence. EVALUATION The award decision will be based on a Lowest Price Technically Acceptable (LPTA) determination. Award will be made on all or none basis. If you are providing an "equal" product, you must submit additional documentation that highlights and describes how your offering is equal in accordance with FAR Clause 52.211-6. PRICE PROPOSAL The Offeror shall prepare a price proposal that contains all information necessary to allow for a comprehensive evaluation of the prices quoted. Specifically, your quote must include the following: Federal Tax Identification Number (TIN); Data Universal Numbering System (DUNS) Number; and Business Size (e.g., small or large).
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/PSC/DAM/N02CO52661-85 /listing.html)
 

Place of Performance

Address: 9609 Medical Center Drive, Rockville, Maryland, 20850, United States

Zip Code: 20850
 

Record

SN03835291-W 20150814/150812235541-f46d47ab625336aff1a3933f0329af4e (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |